drugset / Trial / NCT07795567
A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea.
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this clinical trial is to evaluate and demonstrate the therapeutic equivalence and safety of Ivermectin Cream 1%, Soolantra™ Cream 1%, PrRosiver® Cream 1% \& to Placebo for the treatment of moderate to severe facial rosacea.
Timeline
- Start
- 2025-12-09
- Primary completion
- 2026-06-24
- Completion
- 2026-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivermectin | Small molecule | 1 % | Topical |
| Comparator | PrRosiver® | Unknown | 1 % | Topical |
| Comparator | Soolantra™ | Unknown | 1 % | Topical |